Status:

COMPLETED

Comparison Trial Between Two Repellent Products and a Positive Control Against Culicoides Nubeculosus Midges

Lead Sponsor:

ARCTEC

Conditions:

Midge Bites

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

Comparison trial between two repellent products and a positive control against Culicoides nubeculosus midges. A single-centre laboratory setting study using healthy volunteers to test two insect repel...

Detailed Description

Mosquitoes, midges and other biting insects are vectors of extremely important diseases such as malaria, yellow fever, filariasis and many viruses and also may be of great nuisance value. The use of r...

Eligibility Criteria

Inclusion

  • Able and willing to give fully informed consent;
  • Able to understand and comply with the study procedures;
  • Consider themselves to be in good general health;
  • Male or female;
  • Aged 18 to 65 years;
  • Non-smokers or willing to refrain for 12 hours prior to and during each test;
  • Willing to undergo a bite test with Culicoides nubeculosus midges with up to 72 hour follow-up.

Exclusion

  • Suspected or known to be sensitive or allergic to midge bites;
  • Participated in an interventional study (other than a biting insect challenge study) in the previous 3 months;
  • Participated in a biting insect challenge study in the previous 72 hours;
  • Aware of having any cardiovascular or respiratory disorder (whether active or inactive) (e.g. asthma);
  • Individuals with localized skin disorders affecting the forearm;
  • Allergic to any of the test product ingredients;
  • Extensive tattooing or other conditions of the forearm which would make interpretation of the bite test results difficult;
  • Women who are pregnant, nursing or intending to become pregnant;
  • Previous anaphylaxis;
  • Aware of having a compromised immune system;(an immune system that is temporarily or permanently incapable of working at full capacity);
  • Phobia of flying insects;
  • Travelled to a mosquito-borne disease endemic area in the last 3 months.

Key Trial Info

Start Date :

November 19 2018

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 13 2019

Estimated Enrollment :

15 Patients enrolled

Trial Details

Trial ID

NCT04028180

Start Date

November 19 2018

End Date

February 13 2019

Last Update

July 22 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Arctec at London School of Hygiene & Tropical Medicine

London, United Kingdom, WC1E 7HT